Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

This site uses cookies to store information on your computer. Some cookies on this site are essential and the site won’t work as expected without them. To learn more about cookies and their benefits, please view our cookies policy. You could also decide what kind of cookie the website could use or not use on our cookies settings page.
By closing this message or navigating within the website, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.

Help menu :

  1. Sanofi Worldwide |
  2. Our UK Websites |
  3. Global Business Websites |
  4. Contact us |
  5. Site map |
  6. Help
  1. RSS
  2. Font size

    Reduce font size Increase font size  

Content :

Reducing Cardiovascular Risks

Life is a health journey. Over 400 people in the UK lose their lives to cardiovascular disease (CVD) every single day. High levels of “bad” cholesterol is one of the major risk factors for the most common cardiovascular event, a heart attack. Despite currently available cholesterol-lowering medicines, many people at high-risk of CVD miss their cholesterol goals.

As a health journey partner, Sanofi has significantly invested in the research and development of new therapeutic options for people whose ‘bad’ cholesterol is not controlled by other existing cholesterol-lowering medicines. Thanks to this commitment, thousands of people across the UK could live their life at a lower cardiovascular risk.

Sanofi, Empowering Life.


©Erickson/Jim Erickson/plainpicture


Updated: December 18, 2017